Cargando…

The cost and value of cancer drugs – are new innovations outpacing our ability to pay?

Cancer drug expenditures have been increasing significantly in countries around the world. A recent paper in the IJHPR provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art in...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Daniel A., Stemmer, Salomon M., Gordon, Noa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032240/
https://www.ncbi.nlm.nih.gov/pubmed/27688873
http://dx.doi.org/10.1186/s13584-016-0097-0